7Baggers
 Cellectar Biosciences Presented Compelling Data in Oral  GlobeNewswire Tue, 30 Sep 2025 12:32:04 GMT
 Cellectar and Evestia Clinical Announce Partnership to  GlobeNewswire Wed, 24 Sep 2025 12:22:30 GMT
 cellectar shares edge higher following investor update release  AD HOC NEWS Sun, 21 Sep 2025 14:45:04 GMT
 aug big picture: is cellectar biosciences inc still a buy after recent gains  خودرو بانک Thu, 18 Sep 2025 04:07:25 GMT
 aug big picture: is cellectar biosciences inc still a buy after recent gains  خودرو بانک Wed, 17 Sep 2025 22:06:56 GMT
 cellectar faces nasdaq delisting over share price rule  MSN Tue, 16 Sep 2025 23:49:41 GMT
 Cellectar Biosciences to Participate at Oppenheimer 3rd  GlobeNewswire Tue, 09 Sep 2025 07:00:00 GMT
 is cellectar biosciences inc. a strong candidate for buy and hold  خودرو بانک Thu, 04 Sep 2025 13:35:16 GMT
 Cellectar Biosciences to Present Data in Poster  GlobeNewswire Wed, 03 Sep 2025 07:00:00 GMT
 about us  FinancialContent Wed, 03 Sep 2025 07:00:00 GMT
 published on: 2025-09-01 21:25:14  Newser Tue, 02 Sep 2025 02:25:14 GMT
 published on: 2025-08-31 22:26:13  Newser Mon, 01 Sep 2025 03:26:13 GMT
 cellectar biosciences earnings call: progress amid challenges  TipRanks Mon, 01 Sep 2025 01:15:29 GMT
 Cellectar Biosciences Earnings Call: Progress Amid Challenges  TipRanks Sun, 31 Aug 2025 07:00:00 GMT
 cellectar biosciences q2 2025 earnings preview  MSN Sat, 30 Aug 2025 22:37:47 GMT
 published on: 2025-08-30 13:18:07  Newser Sat, 30 Aug 2025 18:18:07 GMT
 published on: 2025-08-29 15:00:03  Newser Fri, 29 Aug 2025 20:00:03 GMT
 published on: 2025-08-28 23:09:50  Newser Fri, 29 Aug 2025 04:09:50 GMT
 published on: 2025-08-27 22:34:15  Newser Thu, 28 Aug 2025 03:34:15 GMT
 cellectar cuts q2 losses and expenses  AOL.com Wed, 27 Aug 2025 14:12:02 GMT
 Cellectar Biosciences to Present Data in Oral Session and  GlobeNewswire Wed, 27 Aug 2025 07:00:00 GMT
 cellectar biosciences inc. stock chart pattern explained  Newser Mon, 25 Aug 2025 06:21:02 GMT

Cellectar Biosciences, Inc
(NASDAQ:CLRB) 

CLRB stock logo

Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131, which is in Phase II clinical study in patients with relapsed or refr...

Founded: 1996
Full Time Employees: 8
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends